Report cover image

MEA Lung Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Nov 01, 2022
Length 248 Pages
SKU # DAABD17583256

Description

MEA Lung Cancer Diagnostics Market - Industry Trends and Forecast to 2030

The Middle East and Africa lung cancer diagnostics market is projected to register a substantial CAGR of 9.7% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030

Market Segmentation

Middle East and Africa Lung Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Biomarkers Test, Imaging Test, Biopsy, Blood Test, and Others), Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), End User (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, Rest of Middle East and Africa) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Middle East and Africa lung cancer diagnostics market are:

• Rise in prevalence and incidence of lung cancer
• Increase in healthcare expenditure on cancer diagnosis and treatment

Market Players

Some of the major players operating in the Middle East and Africa lung cancer diagnostics market are:

• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott
• Quest Diagnostics Incorporated
• Bio-Rad Laboratories, Inc.
• Biocartis
• Danaher
• DiaSorin S.p.A
• LalPathLabs.com
• NanoString
• PerkinElmer Inc.
• QIAGEN
• Siemens Healthcare GmbH

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

248 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Middle East & Africa Lung Cancer Diagnostics Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Testing Type Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porter’s Five Forces
4.2 Pestel Analysis
4.3 Industry Insights
5 Epidermiology
6 Regulations
7 Market Overview
7.1 Drivers
7.1.1 Unmet Need For Non-invasive, Accurate, And Reliable Diagnostic Tests For Earlier Cancer Detection
7.1.2 Increasing Early Diagnosis Of Lungs Cancer
7.1.3 Increasing Cases Of Lung Cancer
7.1.4 Rise In Product Approvals
7.2 Restraints
7.2.1 Poor & Late Diagnosis Of Lung Cancer
7.2.2 High False-positives And Poor Sensitivity
7.3 Opportunities
7.3.1 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment
7.3.2 Government Initiatives Toward Cancer Diagnostics
7.3.3 Rising Awareness Of Lung Cancer
7.4 Challenges
7.4.1 Stringent Regulatory Framework For The Approval And Commercialization Of Cancer Diagnostic Products
7.4.2 Increased Cost, Safety, And Convenience Issues
7.4.3 Lack Of Skilled And Certified Professionals
8 Middle East & Africa Lung Cancer Diagnostics Market, By Product Type
8.1 Overview
8.2 Instruments
8.2.1 Imaging Instruments
8.2.1.1 Ct Systems
8.2.1.2 Ultrasound Systems
8.2.1.3 Mri Systems
8.2.1.4 Others
8.2.2 Biopsy Instruments
8.2.2.1 Needle Biopsy
8.2.2.2 Endoscopic Biopsy
8.2.2.3 Core Biopsy
8.2.2.4 Others
8.2.3 Pathology-based Instruments
8.2.3.1 Slide Staining Systems
8.2.3.2 Tissue Processing Systems
8.2.3.3 Cell Processors
8.2.3.4 Pcr Instruments
8.2.3.5 Others Pathology-based Instruments
8.3 Consumables And Accessories
8.3.1 Kits
8.3.1.1 Dna Polymerase Kits
8.3.1.2 Nucleic Acid Isolation Kits
8.3.1.3 Pcr Kits
8.3.1.4 Others
8.3.2 Reagents
8.3.2.1 Assays
8.3.2.2 Buffers
8.3.2.3 Primers
8.3.2.4 Others
8.3.3 Probes
8.3.4 Other Consumables
9 Middle East & Africa Lung Cancer Diagnostics Market, By Test Type
9.1 Overview
9.2 Imaging Test
9.2.1 Computed Tomography (Ct) Scan
9.2.2 Positron Emission Tomography (Pet) Scan
9.2.3 Chest X-ray
9.2.4 Bone Scan
9.2.5 Mri
9.2.6 Others
9.3 Biomarkers Test
9.3.1 Egfr Mutation Test
9.3.2 Kras Mutation Test
9.3.3 Alk Test
9.3.4 Her2 Test
9.3.5 Others
9.4 Biopsy
9.4.1 Needle Biopsy
9.4.2 Bronchoscopy Biopsy
9.4.3 Core Biopsy
9.4.4 Others
9.5 Blood Test
9.5.1 Complete Blood Count (Cbc)
9.5.2 Blood Chemistry Tests
9.5.3 Others
9.6 Others
10 Middle East & Africa Lung Cancer Diagnostics Market, By Cancer Type
10.1 Overview
10.2 Non-small Cell Lung Cancer
10.3 Small Cell Lung Cancer
11 Middle East & Africa Lung Cancer Diagnostics Market, By End User
11.1 Overview
11.2 Hospital
11.3 Associated Labs
11.4 Independent Diagnostic Laboratories
11.5 Diagnostic Imaging Centers
11.6 Cancer Research Institutes
11.7 Others
12 Middle East & Africa Lung Cancer Diagnostics Market, By Distribution Channel
12.1 Overview
12.2 Direct Tender
12.3 Retail Sales
13 Middle East & Africa Lung Cancer Diagnostics Market, By Region
13.1 Middle East And Africa
13.1.1 South Africa
13.1.2 Egypt
13.1.3 Saudi Arabia
13.1.4 U.A.E.
13.1.5 Kuwait
13.1.6 Oman
13.1.7 Bahrain
13.1.8 Qatar
13.1.9 Rest Of Middle East And Africa
14 Middle East & Africa Lung Cancer Diagnostics Market, Company Landscape
14.1 Company Share Analysis: Middle East & Africa
15 Swot Analysis
16 Company Profile
16.1 F. Hoffmann-la Roche Ltd. (2022)
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Developments
16.2 Thermo Fisher Scientific Inc. (2022)
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Developments
16.3 Abbott (2022)
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Developments
16.4 Quest Diagnostics Incorporated (2022)
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Developments
16.5 Biodesix (2022)
16.5.1 Company Profile
16.5.2 Revenue Analysis
16.5.3 Company Share Analysis
16.5.4 Product Portfolio
16.5.5 Recent Developments
16.6 Amoy Diagnostics Co., Ltd. (2022)
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Developments
16.7 Bio-rad Laboratories, Inc. (2022)
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Product Portfolio
16.7.4 Recent Developments
16.8 Biocartis (2022)
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Developments
16.9 Boditech Med Inc.
16.9.1 Company Profile
16.9.2 Product Portfolio
16.9.3 Recent Developments
16.10 Danaher (2022)
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Product Portfolio
16.10.4 Recent Developments
16.11 Diasorin S.P.A. (2022)
16.11.1 Company Snapshot
16.11.2 Revenue Analysis
16.11.3 Product Portfolio
16.11.4 Recent Developments
16.12 Exact Sciences Uk, Ltd. (Subsidiary Of Exact Science Corporation) (2022)
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Product Portfolio
16.12.4 Recent Developments
16.13 20/20 Gene Systems
16.13.1 Company Profile
16.13.2 Product Portfolio
16.13.3 Recent Developments
16.14 Guardant Health Inc.
16.14.1 Company Profile
16.14.2 Product Portfolio
16.14.3 Recent Developments
16.15 Inivata Ltd.
16.15.1 Company Profile
16.15.2 Product Portfolio
16.15.3 Recent Developments
16.16 Lalpathlabs.Com (2022)
16.16.1 Company Snapshot
16.16.2 Revenue Analysis
16.16.3 Product Portfolio
16.16.4 Recent Developments
16.17 Lunglife Ai, Inc. (2022)
16.17.1 Company Snapshot
16.17.2 Product Portfolio
16.17.3 Recent Developments
16.18 Medgenome
16.18.1 Company Snapshot
16.18.2 Product Portfolio
16.18.3 Recent Developments
16.19 Myriad Genetics, Inc.
16.19.1 Company Snapshot
16.19.2 Product Portfolio
16.19.3 Recent Developments
16.20 Neogenomics Laboratories (2022)
16.20.1 Company Snapshot
16.20.2 Revenue Analysis
16.20.3 Product Portfolio
16.20.4 Recent Developments
16.21 Nanostring (2022)
16.21.1 Company Snapshot
16.21.2 Revenue Analysis
16.21.3 Product Portfolio
16.21.4 Recent Developments
16.22 Nanoentek
16.22.1 Company Profile
16.22.2 Product Portfolio
16.22.3 Recent Developments
16.23 Oncocyte Corporation
16.23.1 Company Profile
16.23.2 Service Portfolio
16.23.3 Recent Developments
16.24 Perkinelmer Inc
16.24.1 Company Profile
16.24.2 Revenue Analysis
16.24.3 Product Portfolio
16.24.4 Recent Developments
16.25 Plexbio
16.25.1 Company Snapshot
16.25.2 Product Portfolio
16.25.3 Recent Developments 235
List Of Tables
Table 1 Different Types Of Cancer Screening Tests For Different Types Of Cancers
Table 2 Lung Cancer Rates
Table 3 Approved Diagnostics Of Lungs Cancer
Table 4 Middle East & Africa Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 5 Middle East & Africa Instruments In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 6 Middle East & Africa Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 7 Middle East & Africa Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 8 Middle East & Africa Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 9 Middle East & Africa Consumables & Accessories In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 10 Middle East & Africa Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 11 Middle East & Africa Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 12 Middle East & Africa Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 13 Middle East & Africa Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 14 Middle East & Africa Imaging Test In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 15 Middle East & Africa Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 16 Middle East & Africa Biomarkers Test In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 17 Middle East & Africa Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 18 Middle East & Africa Biopsy In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 19 Middle East & Africa Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 20 Middle East & Africa Blood Test In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 21 Middle East & Africa Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 22 Middle East & Africa Others In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 23 Middle East & Africa Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 24 Middle East & Africa Non-small Cell Lung Cancer In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 25 Middle East & Africa Small Cell Lung Cancer In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 26 Middle East & Africa Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 27 Middle East & Africa Hospital In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 28 Middle East & Africa Associated Labs In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 29 Middle East & Africa Independent Diagnostic Laboratories In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 30 Middle East & Africa Diagnostic Imaging Centers In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 31 Middle East & Africa Cancer Research Institutes In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 32 Middle East & Africa Others In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 33 Middle East & Africa Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 34 Middle East & Africa Direct Tender In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 35 Middle East & Africa Retail Sales In Lung Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 36 Middle East And Africa Lung Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
Table 37 Middle East And Africa Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 38 Middle East And Africa Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 39 Middle East And Africa Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 40 Middle East And Africa Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 41 Middle East And Africa Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 42 Middle East And Africa Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 43 Middle East And Africa Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 44 Middle East And Africa Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 45 Middle East And Africa Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 46 Middle East And Africa Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 47 Middle East And Africa Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 48 Middle East And Africa Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 49 Middle East And Africa Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 50 Middle East And Africa Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 51 Middle East And Africa Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 52 Middle East And Africa Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 53 South Africa Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 54 South Africa Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 55 South Africa Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 56 South Africa Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 57 South Africa Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 58 South Africa Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 59 South Africa Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 60 South Africa Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 61 South Africa Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 62 South Africa Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 63 South Africa Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 64 South Africa Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 65 South Africa Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 66 South Africa Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 67 South Africa Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 68 South Africa Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 69 Egypt Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 70 Egypt Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 71 Egypt Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 72 Egypt Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 73 Egypt Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 74 Egypt Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 75 Egypt Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 76 Egypt Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 77 Egypt Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 78 Egypt Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 79 Egypt Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 80 Egypt Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 81 Egypt Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 82 Egypt Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 83 Egypt Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 84 Egypt Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 85 Saudi Arabia Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 86 Saudi Arabia Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 87 Saudi Arabia Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 88 Saudi Arabia Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 89 Saudi Arabia Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 90 Saudi Arabia Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 91 Saudi Arabia Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 92 Saudi Arabia Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 93 Saudi Arabia Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 94 Saudi Arabia Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 95 Saudi Arabia Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 96 Saudi Arabia Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 97 Saudi Arabia Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 98 Saudi Arabia Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 99 Saudi Arabia Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 100 Saudi Arabia Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 101 U.A.E Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 102 U.A.E Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 103 U.A.E Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 104 U.A.E Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 105 U.A.E Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 106 U.A.E Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 107 U.A.E Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 108 U.A.E Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 109 U.A.E Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 110 U.A.E Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 111 U.A.E Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 112 Saudi Arabia Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 113 U.A.E Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 114 U.A.E Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 115 U.A.E Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 116 U.A.E Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 117 Kuwait Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 118 Kuwait Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 119 Kuwait Pathology-based Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 120 Kuwait Imaging Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 121 Kuwait Biopsy Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 122 Kuwait Consumables And Accessories In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 123 Kuwait Kits In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 124 Kuwait Reagents In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 125 Kuwait Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 126 Kuwait Biomarkers Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 127 Kuwait Imaging Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 128 Kuwait Biopsy In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 129 Kuwait Blood Test In Lung Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 130 Kuwait Lung Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 131 Kuwait Lung Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 132 Kuwait Lung Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 133 Oman Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 134 Oman Instruments In Lung Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million) 146
List Of Figures
Figure 1 Middle East & Africa Lung Cancer Diagnostics Market: Segmentation
Figure 2 Middle East & Africa Lung Cancer Diagnostics Market: Data Triangulation
Figure 3 Middle East & Africa Lungs Cancer Diagnostics Market: Droc Analysis
Figure 4 Middle East & Africa Lung Cancer Diagnostics Market: Middle East & Africa Vs Regional Market Analysis
Figure 5 Middle East & Africa Lung Cancer Diagnostic Market: Company Research Analysis
Figure 6 Middle East & Africa Lung Cancer Diagnostics Market: Interview Demographics
Figure 7 Middle East & Africa Lung Cancer Diagnostics Market: Dbmr Market Position Grid
Figure 8 Middle East & Africa Lung Cancer Diagnostics Market: Market End User Coverage Grid
Figure 9 Middle East & Africa Lung Cancer Diagnostics Market: Vendor Share Analysis
Figure 10 Middle East & Africa Lung Cancer Diagnostics Market: Segmentation
Figure 11 The Increase In The Awareness About Lung Cancer Is Expected To Drive The Middle East & Africa Lung Cancer Diagnostics Market In The Forecast Period
Figure 12 Instruments Segment Is Expected To Account For The Largest Share Of The Middle East & Africa Lung Cancer Diagnostics Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Middle East & Africa Lung Cancer Diagnostics Market
Figure 14 The Middle East & Africa Mortality Rate Due To Cancer
Figure 15 The Data Given Below Shows The Increasing Middle East & Africa Cancer Rate In 2020
Figure 16 Barriers To Early Cancer Diagnosis And Treatment
Figure 17 Middle East & Africa Lung Cancer Diagnostics Market: By Product Type, 2022
Figure 18 Middle East & Africa Lung Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
Figure 19 Middle East & Africa Lung Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
Figure 20 Middle East & Africa Lung Cancer Diagnostics Market: By Product Type, Lifeline Curve
Figure 21 Middle East & Africa Lung Cancer Diagnostics Market: By Test Type, 2022
Figure 22 Middle East & Africa Lung Cancer Diagnostics Market: By Test Type, 2023-2030 (Usd Million)
Figure 23 Middle East & Africa Lung Cancer Diagnostics Market: By Test Type, Cagr (2023-2030)
Figure 24 Middle East & Africa Lung Cancer Diagnostics Market: By Test Type, Lifeline Curve
Figure 25 Middle East & Africa Lung Cancer Diagnostics Market: By Cancer Type, 2022
Figure 26 Middle East & Africa Lung Cancer Diagnostics Market: By Cancer Type, 2023-2030 (Usd Million)
Figure 27 Middle East & Africa Lung Cancer Diagnostics Market: By Cancer Type, Cagr (2023-2030)
Figure 28 Middle East & Africa Lung Cancer Diagnostics Market: By Cancer Type, Lifeline Curve
Figure 29 Middle East & Africa Lung Cancer Diagnostics Market: By End User, 2022
Figure 30 Middle East & Africa Lung Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
Figure 31 Middle East & Africa Lung Cancer Diagnostics Market: By End User, Cagr (2023-2030)
Figure 32 Middle East & Africa Lung Cancer Diagnostics Market: By End User, Lifeline Curve
Figure 33 Middle East & Africa Lung Cancer Diagnostics Market: By Distribution Channel, 2022
Figure 34 Middle East & Africa Lung Cancer Diagnostics Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 35 Middle East & Africa Lung Cancer Diagnostics Market: By Distribution Channel, Cagr (2023-2030)
Figure 36 Middle East & Africa Lung Cancer Diagnostics Market: By Distribution Channel, Lifeline Curve
Figure 37 Middle East And Africa Lung Cancer Diagnostics Market: Snapshot (2022)
Figure 38 Middle East And Africa Lung Cancer Diagnostics Market: By Country (2022)
Figure 39 Middle East And Africa Lung Cancer Diagnostics Market: By Country (2023 & 2030)
Figure 40 Middle East And Africa Lung Cancer Diagnostics Market: By Country (2022 & 2030)
Figure 41 Middle East And Africa Lung Cancer Diagnostics Market: By Product Type (2023-2030)
Figure 42 Middle East & Africa Lung Cancer Diagnostics Market: Company Share 2022 (%) 161

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us